| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 89, 2525-2532, Copyright © 1994 by American Heart Association
AM Zeiher, V Schachlinger, SH Hohnloser, B Saurbier and H Just
BACKGROUND: Abnormal vascular reactivity represents a fundamental
disturbance in vascular biology with the development of atherosclerosis.
Because endothelial vasodilator function plays a pivotal role in
controlling vasomotor tone, we hypothesized that atherosclerotic wall
thickening might directly interfere with deficient endothelium-mediated
dilation and thereby contribute to the abnormal reactivity of
atherosclerotic arteries in vivo. METHODS AND RESULTS: In 26 patients
without focal stenoses in the left anterior descending coronary artery,
acetylcholine (0.036 to 3.6 micrograms/mL) was infused into the artery to
evaluate endothelium-mediated vasodilation. Segmental vasomotor responses
to acetylcholine were correlated with the local extent of atherosclerotic
wall thickening quantitated by intracoronary ultrasound examination.
Seventeen of the patients also underwent cold pressor testing to assess the
vasoreactivity to sympathetic activation. The response of coronary artery
segments to acetylcholine varied from 35% dilation to 52% constriction and
demonstrated a segmental pattern, with dilation and constriction observed
in different segments of the same artery. The vasomotor response to
acetylcholine was closely correlated with the extent of local
atherosclerotic wall thickening (r = -.82, P < .0001). Over the entire
range of atherosclerotic wall thickening, segments from patients with
elevated high-density lipoprotein (HDL) cholesterol serum levels (> 75th
percentile) demonstrated a significantly blunted constrictor response to
acetylcholine (P < .01 at the maximal acetylcholine concentration)
compared with segments from patients with HDL cholesterol < 75th
percentile. The degree of constriction or dilation in response to the
acetylcholine infusion correlated with the response to cold pressor testing
(r = .75, P < .0001). Again, the cold pressor test-induced constrictor
response was significantly (P < .05) blunted in segments from patients
with elevated HDL cholesterol serum levels compared with those from
patients with HDL cholesterol < 75th percentile despite equal degrees of
atherosclerotic wall thickening. CONCLUSIONS: Coronary vasomotor responses
to the endothelium-dependent dilator acetylcholine and to sympathetic
stimulation by cold pressor test correlate with local atherosclerotic wall
thickening. Thus, the degree of abnormal local vascular reactivity is
closely related to the extent of atherosclerotic "plaque load" in human
epicardial arteries in vivo. Elevated HDL cholesterol serum levels
ameliorate abnormal vasoconstriction at any given extent of atherosclerotic
wall thickening, suggesting that HDL cholesterol exerts a beneficial effect
on abnormal vascular reactivity, a fundamental functional disturbance
associated with coronary atherosclerosis.
ARTICLES
Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis
Department of Internal Medicine III, Universitatsklinik Freiburg, Germany.
This article has been cited by other articles:
 |
|
 |
|
  D J Hausenloy and D M Yellon Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels Postgrad. Med. J., November 1, 2008; 84(997): 590 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J Hausenloy and D M Yellon Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels Heart, June 1, 2008; 94(6): 706 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ruel, R. S. Beanlands, M. Lortie, V. Chan, N. Camack, R. A. deKemp, E. J. Suuronen, F. D. Rubens, J. N. DaSilva, F. W. Sellke, et al. Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: The Endothelial Modulation in Angiogenic Therapy randomized controlled trial. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 762 - 770.e1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yu, K. Murao, H. Imachi, W.-M. Cao, J. Li, K. Matsumoto, T. Nishiuchi, R. A.M. Ahmed, N. C.W. Wong, H. Kosaka, et al. Regulation of Scavenger Receptor Class BI Gene Expression by Angiotensin II in Vascular Endothelial Cells Hypertension, June 1, 2007; 49(6): 1378 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Mineo, H. Deguchi, J. H. Griffin, and P. W. Shaul Endothelial and Antithrombotic Actions of HDL Circ. Res., June 9, 2006; 98(11): 1352 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Mineo and P. W. Shaul Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae Cardiovasc Res, April 1, 2006; 70(1): 31 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kaul, B. Coin, A. Hedayiti, J. Yano, B. Cercek, K.-Y. Chyu, and P. K. Shah Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-IMilano-phospholipid complex J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1311 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Badesch, S. H. Abman, G. S. Ahearn, R. J. Barst, D. C. McCrory, G. Simonneau, and V. V. McLaughlin Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Chest, July 1, 2004; 126(1_suppl): 35S - 62S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.J. Chapman Are the effects of statins on HDL-cholesterol clinically relevant? Eur. Heart J. Suppl., July 1, 2004; 6(suppl_C): C58 - C63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Calabresi, M. Gomaraschi, and G. Franceschini Endothelial Protection by High-Density Lipoproteins: From Bench to Bedside Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1724 - 1731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Crauwels, C. E. Van Hove, P. Holvoet, A. G. Herman, and H. Bult Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI Cardiovasc Res, July 1, 2003; 59(1): 189 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Taddei, A. Virdis, L. Ghiadoni, D. Versari, G. Salvetti, A. Magagna, and A. Salvetti Calcium Antagonist Treatment by Lercanidipine Prevents Hyperpolarization in Essential Hypertension Hypertension, April 1, 2003; 41(4): 950 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. W. Booth, M. V. Chakravarthy, S. E. Gordon, and E. E. Spangenburg Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy J Appl Physiol, July 1, 2002; 93(1): 3 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Calabresi, M. Gomaraschi, B. Villa, L. Omoboni, C. Dmitrieff, and G. Franceschini Elevated Soluble Cellular Adhesion Molecules in Subjects With Low HDL-Cholesterol Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 656 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Fukuda, H Teragawa, K Matsuda, T Yamagata, H Matsuura, and K Chayama Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia Heart, March 1, 2002; 87(3): 264 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. De Bruyne, F. Hersbach, N. H.J. Pijls, J. Bartunek, J.-W. Bech, G. R. Heyndrickx, K. L. Gould, and W. Wijns Abnormal Epicardial Coronary Resistance in Patients With Diffuse Atherosclerosis but "Normal" Coronary Angiography Circulation, November 13, 2001; 104(20): 2401 - 2406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Shah, S. Kaul, J. Nilsson, and B. Cercek Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I Circulation, November 6, 2001; 104(19): 2376 - 2383. [Full Text] [PDF]
|
|
|
|
|
|
M. Hernandez-Pampaloni, F. Y.J. Keng, T. Kudo, J. S. Sayre, and H. R. Schelbert Abnormal Longitudinal, Base-to-Apex Myocardial Perfusion Gradient by Quantitative Blood Flow Measurements in Patients With Coronary Risk Factors Circulation, July 31, 2001; 104(5): 527 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lundman, M. J. Eriksson, M. Stuhlinger, J. P. Cooke, A. Hamsten, and P. Tornvall Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine J. Am. Coll. Cardiol., July 1, 2001; 38(1): 111 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. de Roos, M. L. Bots, and M. B. Katan Replacement of Dietary Saturated Fatty Acids by Trans Fatty Acids Lowers Serum HDL Cholesterol and Impairs Endothelial Function in Healthy Men and Women Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1233 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Haegeli, K. Quitzau, T.F. Luscher, and Steering Committee and the Investigators of the EN From endothelial dysfunction to clinical events Concept and update on the ENCORE trials Eur. Heart J. Suppl., May 1, 2001; 3(suppl_B): B12 - B19. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Paolisso, D. Manzella, M. R. Tagliamonte, M. Barbieri, R. Marfella, G. Zito, M. Bonafè, D. Giugliano, C. Franceschi, and M. Varricchio The BB-Paraoxonase Genotype Is Associated with Impaired Brachial Reactivity after Acute Hypertriglyceridemia in Healthy Subjects J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1078 - 1082. [Abstract] [Full Text]
|
|
|
|
|
|
K. J. Mather, S. Verma, B. Corenblum, and T. J. Anderson Normal Endothelial Function Despite Insulin Resistance in Healthy Women with the Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1851 - 1856. [Abstract] [Full Text]
|
|
|
|
|
|
K. J. Williams, R. Scalia, K. D. Mazany, W. V. Rodrigueza, and A. M. Lefer Rapid Restoration of Normal Endothelial Functions in Genetically Hyperlipidemic Mice by a Synthetic Mediator of Reverse Lipid Transport Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1033 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Mostaza, M. V. Gomez, F. Gallardo, M. L. Salazar, R. Martin-Jadraque, L. Plaza-Celemin, I. Gonzalez-Maqueda, and L. Martin-Jadraque Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels J. Am. Coll. Cardiol., January 1, 2000; 35(1): 76 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Deckert, G. Lizard, N. Duverger, A. Athias, V. Palleau, F. Emmanuel, M. Moisant, P. Gambert, C. Lallemant, and L. Lagrost Impairment of Endothelium-Dependent Arterial Relaxation By High-Fat Feeding in ApoE-Deficient Mice : Toward Normalization By Human ApoA-I Expression Circulation, September 14, 1999; 100(11): 1230 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Drexler Nitric oxide and coronary endothelial dysfunction in humans Cardiovasc Res, August 15, 1999; 43(3): 572 - 579. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Egermayer, G I. Town, and A. J Peacock Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension Thorax, February 1, 1999; 54(2): 161 - 168. [Full Text]
|
|
|
|
|
|
K. Miwa, N. Yoshida, K. Nakagawa, and H. Inoue High-density lipoprotein particles are large in patients with variant angina Cardiovasc Res, March 1, 1998; 37(3): 729 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lundman, M. Eriksson, K. Schenck-Gustafsson, F. Karpe, and P. Tornvall Transient Triglyceridemia Decreases Vascular Reactivity in Young, Healthy Men Without Risk Factors for Coronary Heart Disease Circulation, November 18, 1997; 96(10): 3266 - 3268. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. G. M. Clarijs, G. Pasterkamp, A. H. Schoneveld, T. G. van Leeuwen, B. Hillen, and C. Borst Compensatory Enlargement in Coronary and Femoral Arteries Is Related to Neither the Extent of Plaque-Free Vessel Wall Nor Lesion Eccentricity : A Postmortem Study Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2617 - 2621. [Abstract] [Full Text]
|
|
|
|
|
|
M. K. Hong, J. Vossoughi, G. S. Mintz, R. D. Kauffman, R. F. Hoyt Jr, J. F. Cornhill, E. E. Herderick, M. B. Leon, and J. M. Hoeg Altered Compliance and Residual Strain Precede Angiographically Detectable Early Atherosclerosis in Low-Density Lipoprotein Receptor Deficiency Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2209 - 2217. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Matsumoto, A. Mitchell, H. Kurata, L. Pyle, K. Kondo, H. Itakura, and N. Fidge Cloning and Characterization of HB2, a Candidate High Density Lipoprotein Receptor. SEQUENCE HOMOLOGY WITH MEMBERS OF THE IMMUNOGLOBULIN SUPERFAMILY OF MEMBRANE PROTEINS J. Biol. Chem., July 4, 1997; 272(27): 16778 - 16782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Quyyumi, D. Mulcahy, N. P. Andrews, S. Husain, J. A. Panza, and R. O. Cannon III Coronary Vascular Nitric Oxide Activity in Hypertension and Hypercholesterolemia: Comparison of Acetylcholine and Substance P Circulation, January 7, 1997; 95(1): 104 - 110. [Abstract] [Full Text]
|
|
|
|
|
|
V. Schachinger and A. M. Zeiher Quantitative Assessment of Coronary Vasoreactivity in Humans In Vivo : Importance of Baseline Vasomotor Tone in Atherosclerosis Circulation, October 15, 1995; 92(8): 2087 - 2094. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Zeiher, V. Schachinger, and J. Minners Long-term Cigarette Smoking Impairs Endothelium-Dependent Coronary Arterial Vasodilator Function Circulation, September 1, 1995; 92(5): 1094 - 1100. [Abstract] [Full Text]
|
|
|
|
|
|
T. Kuga, K. Egashira, M. Mohri, H. Tsutsui, Y. Harasawa, Y. Urabe, S. Ando, H. Shimokawa, and A. Takeshita Bradykinin-Induced Vasodilation Is Impaired at the Atherosclerotic Site but Is Preserved at the Spastic Site of Human Coronary Arteries In Vivo Circulation, July 15, 1995; 92(2): 183 - 189. [Abstract] [Full Text]
|
|
|
|
|
|
G. K. Goode and A. M. Heagerty In Vitro Responses of Human Peripheral Small Arteries in Hypercholesterolemia and Effects of Therapy Circulation, June 15, 1995; 91(12): 2898 - 2903. [Abstract] [Full Text]
|
|
|
|
|
|
S. Nakatani, M. Yamagishi, J. Tamai, Y. Goto, T. Umeno, A. Kawaguchi, C. Yutani, and K. Miyatake Assessment of Coronary Artery Distensibility by Intravascular Ultrasound : Application of Simultaneous Measurements of Luminal Area and Pressure Circulation, June 15, 1995; 91(12): 2904 - 2910. [Abstract] [Full Text]
|
|
|
|
|
|
L. Calabresi, M. Gomaraschi, B. Villa, L. Omoboni, C. Dmitrieff, and G. Franceschini Elevated Soluble Cellular Adhesion Molecules in Subjects With Low HDL-Cholesterol Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 656 - 661. [Abstract] [Full Text] [PDF]
|
|